SEKONDER İMMÜN YETMEZLİK TANISI KONULAN BİR PNÖMONİ OLGU SUNUMU

Öz

Pnömoni klinik olarak; balgamlı öksürük, pürülan balgam, dispne ve/veya takipne, akciğer grafisinde infiltrasyonlarla birlikte olan plöritik göğüs ağrısı semptom ve bulgularından iki veya daha fazlasının olmasıdır. İmmun yetmezlik; organizmanın immun sistemde zayıflama ya da yetmezlik nedeniyle, enfeksiyon ajanlarına karşı beklenen yanıtı verememesi durumudur. Akciğerler immün yetmezlik hastalıklarında etkilenen doku ve organların başında gelmektedir, efektif tedavi edilemediği durumlarda komplike olabilmektedir. Bu sebeple immun yetmezlik zemininde gelişen pnömöni olgusunu, toplum kökenli pnömöniden ayırt etmek ve tedavinin erken başlanması olası komplikasyonları önlemek açısından oldukça önemlidir.

Anahtar Kelimeler

• pnömoni
• immunyetmezlik
• nefrotik sendrom

A CASE REPORT OF PNEUMONIA DIAGNOSED WITH SECONDARY IMMUNODEFICIENCY

Öz

Pneumonia clinically; Cough with sputum, purulent sputum, dyspnea and/or tachypnea, two or more of the symptoms and signs of pleuritic chest pain with infiltrations on chest X-ray. Immunodeficiency; It is the inability of the organism to give the expected response to infectious agents due to weakening or insufficiency in the immune system. Lungs are one of the tissues and organs affected in immunodeficiency diseases, and can be complicated when they cannot be treated effectively. For this reason, it is very important to distinguish pneumonia on the basis of immunodeficiency from community-acquired pneumonia and to initiate treatment early in order to prevent possible complications.

Anahtar Kelimeler

• pneumonia
• immunodeficiency
• nephrotic syndrome

Kaynakça

1. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Douglas Campbell G, Dean NC, et al. IDSA/ATS Guidelines for CAP in Adults • CID 2007:44 (Suppl 2) • S27 Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. 9.
2. Ramirez JA. Community-acquired pneumonia in adults. Prim Care [Internet]. 2003 [cited 2024 Jan 5];30(1):155–71. Available from: https://pubmed.ncbi.nlm.nih.gov/12825254/
3. Grippi MA, Elias J, Fishman A, Kotloff R, Pack A, Senior R. Fishman’s Pulmonary Diseases and Disorders. 4th ed. McGraw-Hill Professional; 1966-71.
4. Palange P, Rohde GGU 1971. Respiratory medicine.
5. Rubin RH, Peterson PK. Overview of pneumonia in the compromised host. Semin Respir Infect 1986; 1: 131-2.
6. Peck KR, Kim TJ, Lee MA, Lee KS, Han J. Pneumonia in immunocompromised patients: updates in clinical and imaging features. Precision and Future Medicine [Internet]. 2018 Sep 30 [cited 2024 Jan 5];2(3):95–108. Available from: http://www.pfmjournal.org/journal/view.php?number=42
7. Alfakeekh K, Azar M, Sowailmi B Al, Alsulaiman S, Makdob S Al, Omair A, et al. Immunosuppressive burden and risk factors of infection in primary childhood nephrotic syndrome. J Infect Public Health [Internet]. 2019 Jan 1 [cited 2024 Jan 16];12(1):90–4. Available from: https://pubmed.ncbi.nlm.nih.gov/30279098/
8. Patrawala M, Cui Y, Peng L, Fuleihan RL, Garabedian EK, Patel K, et al. Pulmonary Disease Burden in Primary Immune Deficiency Disorders: Data from USIDNET Registry. J Clin Immunol [Internet]. 2020 Feb 1 [cited 2024 Jan 16];40(2):340–9. Available from: https://pubmed.ncbi.nlm.nih.gov/31919711/

9. Hiorns MP, Screaton NJ, Müller NL. Acute lung disease in the immunocompromised host. Radiol Clin North Am [Internet]. 2001 [cited 2024 Jan 16];39(6):1137–51. Available from: https://pubmed.ncbi.nlm.nih.gov/11699665/